Olaparib in Metastatic Castration-Resistant Prostate Cancer

被引：2
|
作者：
Hussain, Maha [1 ]
Desai, Chintu [2 ]
de Bono, Johann [3 ]
机构：
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] AstraZeneca, Cambridge, England
[3] Inst Canc Res, London, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 12期
关键词：
D O I：
10.1056/NEJMc2100225
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1174 / 1176
页数：3
相关论文
共 50 条
  • [21] International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review
    Matveev, V. B.
    Khalmurzaev, O. A.
    Evsyukova, O., I
    ONKOUROLOGIYA, 2020, 16 (04): : 197 - 206
  • [22] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [23] Advances in metastatic castration-resistant prostate cancer
    Kentepozidis, Nikolaos
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S108 - S108
  • [24] Management of Metastatic Castration-Resistant Prostate Cancer
    Srinivas, Sandy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 614 - 616
  • [25] Rucaparib in castration-resistant, metastatic prostate cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2024, 55 (02) : 96 - 98
  • [26] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [27] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [28] Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective
    Matsumoto, Takashi
    Shiota, Masaki
    Blas, Leandro
    Eto, Masatoshi
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2389 - 2397
  • [29] CRLX101 plus olaparib in patients with metastatic castration-resistant prostate cancer.
    Chen, Gang
    Karzai, Fatima
    Madan, Ravi Amrit
    Cordes, Lisa M.
    Bilusic, Marijo
    Owens, Helen
    Hankin, Amy
    Williams, Monique
    Couvillon, Anna
    Gulley, James L.
    Dahut, William L.
    Thomas, Anish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer
    Maughan, Benjamin L.
    Antonarakis, Emmanuel S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (12) : 1625 - 1632
12345